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Until recently, most systematic studies in bipolar disorder
concentrated on reduction of illness severity as the pri-
mary outcome measure. However, functional disabilities
even in euthymic phases are a key issue [1] and improving
quality of life in different domains as work, family and
social activities appears to be of utmost importance for
patients as a recent WHO survey shows. Especially in
bipolar depression, functionality of patients appears
severely impaired throughout several domains [2]. As
demonstrated by Hirschfeld et al. [3] this impairment
appears more severe in bipolar compared to unipolar
depression. Thus, not only reducing depressive symp-
tomatology but also improving quality of life should be a
primary target for any new treatment option, both phar-
macological and non-pharmacological. Psychotherapy,
even just psychoeducation, can clearly improve coping
with the illness and by this also improve quality of life [4].
In addition, some new pharmacological treatment
options as the atypical antipsychotic quetiapine could
demonstrate that they are not only improving depressive
symptomatology in bipolar depression, but also signifi-
cantly improve quality of life as measured with the Q-LES-
Q (Quality of Life Enjoyment and Satisfaction Question-
naire: 16-item short form [5]).
Measuring quality of life as a important outcome parame-
ter in controlled studies may contribute to make those
studies and new medications also more meaningful for
patients.
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